SpectruMedix and Capital Genomix to Couple, Co-Market Products for Gene-Expression Analysis | GenomeWeb

NEW YORK, May 4 (GenomeWeb News) - SpectruMedix of State College, Pa., and Capital Genomix of Gaithersburg, Md., will market and distribute Capital's gene expression-analysis platform for capillary electrophoresis-based applications, the companies said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.